Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: Principal component analysis on high dimensional data

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 912-919

  Liang, Yun ^a   Messer, Karen ^b   Rose, Brent S ^a   Lewis, John H ^a   Jiang, Steve B ^a   Yashar, Catheryn M ^a   Mundt, Arno J ^a   Mell, Loren K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cervical cancer; Chemoradiotherapy; Deformable image registration; Hematologic toxicity; Principal component analysis

Indexed keywords

CERVICAL CANCERS; CHEMORADIOTHERAPY; DEFORMABLE IMAGE REGISTRATION; HEMATOLOGIC TOXICITY; PRINCIPAL COMPONENTS;

BLOOD; BONE; CLUSTERING ALGORITHMS; DEFORMATION; DOSIMETRY; EIGENVALUES AND EIGENFUNCTIONS; IMAGE REGISTRATION; MICROCOMPUTERS; PATIENT MONITORING; PLATINUM COMPOUNDS; RADIATION EFFECTS; RADIOTHERAPY; REGRESSION ANALYSIS; TOXICITY;

PRINCIPAL COMPONENT ANALYSIS;

CISPLATIN; ANTINEOPLASTIC AGENT;

ACUTE TOXICITY; ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOCYTE COUNT; ORGAN SIZE; PELVIC GIRDLE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; BONE MARROW CELL; DRUG EFFECTS; LEUKOCYTE; LEUKOPENIA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PELVIS; PROCEDURES; RADIATION RESPONSE; RADIOGRAPHY; STATISTICAL MODEL; UTERINE CERVICAL NEOPLASMS;

ANTINEOPLASTIC AGENTS; BONE MARROW; BONE MARROW CELLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LEUKOPENIA; LINEAR MODELS; MIDDLE AGED; PELVIC BONES; PELVIS; PRINCIPAL COMPONENT ANALYSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 77957202934     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.11.062     Document Type: Article

References (45)

1. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
2. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study J Clin Oncol 17 1999 1339 1348
3. M. Morris, P.J. Eifel, and J.D. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
4. W.A. Peters, P.Y. Liu, and R.J. Barrett Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
5. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
6. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial JAMA 299 2008 1914 1921
7. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539
8. UKCCCR Anal Cancer Trial Working Party and UK Co-ordinating Committee on Cancer Research Epidermoid anal cancer: Results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049 1054
9. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049
10. A. Dueñas-Gonzalez, L. Cetina-Perez, and C. Lopez-Graniel Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized phase II study Int J Radiat Oncol Biol Phys 61 2005 817 823
11. A. Dueñas-González, J.J. Zarba, and J.C. Alcedo A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 2009 CRA5507
12. J.K. Salama, L.K. Mell, and D.A. Schomas Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience J Clin Oncol 25 2007 4581 4586
13. R. Pearcey, M. Brundage, and P. Drouin Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972
14. M.A. Torres, A. Jhingran, and H.D. Thames Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment Int J Radiat Oncol Biol Phys 70 2008 118 125
15. K. Parker, E. Gallop-Evans, and L. Hanna Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: Results from a single institution Int J Radiat Oncol Biol Phys 74 2009 140 146
16. P. Mauch, L. Constine, and J. Greenberger Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy Int J Radiat Oncol Biol Phys 31 1995 1319 1339
17. V. Blomlie, E.K. Rofstad, and A. Skjonsberg Female pelvic bone marrow: Serial MR Imaging before, during, and after radiation therapy Radiology 194 1995 537 543
18. L.F. Fajardo, M. Berthrong, and R.E. Anderson Hematopoietic tissue L.F. Fajardo, M. Berthrong, R.E. Anderson, Radiation pathology 2001 Oxford University Oxford 379 388
19. P. Rubin, S. Landman, and E. Mayer Bone marrow regeneration and extension after extended field irradiation in Hodgkins disease Cancer 32 1973 699 711
20. L.K. Mell, J.D. Kochanski, and J.C. Roeske Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy Int J Radiat Oncol Biol Phys 2006 1356 1365
21. L.K. Mell, D.A. Schomas, and J.K. Salama Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 2008 1431 1437
22. P. Xia, H.I. Amols, and C.C. Ling Three-dimensional conformal radiotherapy and intensity-modulated radiotherapy S.A. Leibel, T.L. Phillips, Textbook of radiation oncology 2004 Elsevier Philadelphia
23. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
24. L.K. Mell, H. Tiryaki, and K.H. Ahn Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer Int J Radiat Oncol Biol Phys 71 2008 1504 1510
25. L.L. Kestin, M.B. Sharpe, and R.C. Frazier Intensity modulation to improve dose uniformity with tangential breast radiotherapy: Initial clinical experience Int J Radiat Oncol Biol Phys 48 2000 1559 1568
26. C. Burman, C.S. Chui, and G. Kutcher Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 39 1997 863 873
27. C.C. Ling, C. Burman, and C.S. Chui Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation Int J Radiat Oncol Biol Phys 35 1996 721 730
28. K. Sultanem, H.K. Shu, and P. Xia Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience Int J Radiat Oncol Biol Phys 48 2000 711 722
29. A.E. Lujan, A.J. Mundt, and S.D. Yamada Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2003 516 521
30. J.B. Vogler, and W.A. Murphy Bone marrow imaging Radiology 168 1988 679 693
31. J.C. Roeske, and A.J. Mundt Incorporation of magnetic resonance imaging into intensity modulated whole pelvic radiation therapy treatment planning to reduce the volume of pelvic bone marrow irradiated Int Congr Ser 1268 2004 307 312
32. S. Basu, M. Houseni, and G. Bural Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: A novel application with significant implications for combined structure-function approach Mol Imaging Biol 9 2007 361 365
33. J.C. Roeske, A. Lujan, and R.C. Reba Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies Radiother Oncol 77 2005 11 17
34. R.E. Ellis Distribution of active bone marrow in adult Phys Med Biol 5 1961 255
35. S. Mutyala, N. Thawani, and J.M. Vainshtein Dose constraint recommendations and a predictive nomogram of incidence of hematological toxicity for cervix cancer patients treated with concurrent cisplatin and intensity modulated radiation therapy (IMRT) Int J Radiat Oncol Biol Phys 72 2008 S359 S360
36. D. Yang, H. Li, and D.A. Low A fast inverse consistent deformable image registration method based on symmetric optical flow computation Phys Med Biol 53 2008 6143 6165
37. I.T. Jolliffe Principal component analysis 2nd edition 2002 Springer Philadelphia
38. M. Skala, T. Rosewall, and L. Dawson Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 68 2007 690 698
39. M. Sohn, M. Alber, and D. Yan Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity Int J Radiat Oncol Biol Phys 69 2007 230 239
40. L.A. Dawson, M. Biersack, and G. Lockwood Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation Int J Radiat Oncol Biol Phys 2005 829 837
41. M.G. Borgognonea, J. Bussia, and G. Hough Principal component analysis in sensory analysis: Covariance or correlation matrix? Food Quality and Preference 12 2001 323 326
42. J. Green, J. Kirwan, and J. Tierney Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 2005 CD002225
43. Rose BS, Aydogan B, Yeginer M. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. In press.
44. S.B. Reeder, A.R. Pineda, and Z. Wen Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): Application with fast spin-echo imaging Magn Reson Med 54 2005 636 644
45. L.K. Mell, Y. Liang, and M. Bydder Functional MRI-guided bone marrow-sparing intensity modulated radiotherapy for pelvic malignancies Int J Radiat Oncol Biol Phys 75 2009 S121